V
Viol Dhea Kharisma
Researcher at University of Brawijaya
Publications - 51
Citations - 482
Viol Dhea Kharisma is an academic researcher from University of Brawijaya. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 23 publications receiving 66 citations.
Papers
More filters
Journal ArticleDOI
Herbal combination from Moringa oleifera Lam. and Curcuma longa L. as SARS-CoV-2 antiviral via dual inhibitor pathway: A viroinformatics approach
Viol Dhea Kharisma,Aggy Agatha,Arif Nur Muhammad Ansori,Muhammad Hermawan Widyananda,Wahyu Choirur Rizky,Tim Godefridus Antonius Ding,Marina Derkho,I. Lykasova,Yulanda Antonius,Imam Rosadi,Rahadian Zainul +10 more
TL;DR: In this paper , a combination of Moringa oleifera Lam and Curcuma longa L. is predicted to have antiviral and anti-inflammatory activity through dual inhibitor mechanism played by cryptochlorogenic acid and curcumin.
Book ChapterDOI
Retrieval and Investigation of Data on SARS-CoV-2 and COVID-19 Using Bioinformatics Approach.
Muhamad Fahmi,Muhamad Fahmi,Viol Dhea Kharisma,Arif Nur Muhammad Ansori,Masahiro Ito,Masahiro Ito +5 more
TL;DR: In this article, the authors report essential bioinformatics entities, such as database and platform development, molecular evolution and phylogenetic analyses, and vaccine designs, that are useful to solve the SARS-CoV-2 conundrum.
Journal ArticleDOI
Genetic variant of SARS-CoV-2 isolates in Indonesia: Spike glycoprotein gene
Arif Nur Muhammad Ansori,Viol Dhea Kharisma,Sahal Sabilil Muttaqin,Yulanda Antonius,Arli Aditya Parikesit +4 more
TL;DR: Interestingly, there were no significant changes in the genetic composition of SARS-CoV-2 spike glycoprotein genes, when compared to the Wuhan- Hu-1 isolate from China, however, this is a preliminary study and it is recommended that molecular epidemiology and surveillance programs against COVID-19 in Indonesia be improved.
Journal ArticleDOI
Distribution of COVID-19 and phylogenetic tree construction of sars-CoV-2 in Indonesia
TL;DR: The distribution of COVID-19 in Indonesia and the SARS-CoV-2 phylogenetic tree from Indonesian isolates and those from other countries, including other CoVs to determine their relationship were described.
Journal ArticleDOI
Construction of epitope-based peptide vaccine against SARS-CoV-2: Immunoinformatics study
TL;DR: Interestingly, Pep-4 ADHQPQTFVNTELH is recommended as a epitope-based peptide vaccine candidate to deal with the SARS-CoV-2 outbreak, which has a high level of immunogenicity and does not trigger autoimmune mechanisms.